Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Publications: Berry, Cassandra

Stats for Berry, Cassandra
Export as [feed] RSS
Group by: Item Type | Year
Number of items: 77.

Journal Article

Berry, C.M. (2017) A technique for inspiring scientific inquiry using a creative scenario. The American Biology Teacher, 79 (8). pp. 671-677.

Castley, A., Williams, L., James, I., Guelfi, G., Berry, C. and Nolan, D. (2016) Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors. PloS one, 11 (6). e0158169.

Berry, C.M. (2016) Understanding interferon subtype therapy for viral infections: Harnessing the power of the innate immune system. Cytokine & Growth Factor Reviews, 31 . pp. 83-90.

Berry, C.M. (2015) Towards a universal influenza virus vaccine eliciting broadly neutralising haemagglutinin antibodies. Journal of Vaccines & Vaccination, 06 (06).

Castley, A., Berry, C.M., French, M., Fernandez, S., Krueger, R. and Nolan, D. (2014) Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: A changing paradigm for routine HIV laboratory monitoring? PLoS ONE, 9 (12). e115226.

Cha, L., Berry, C.M., Nolan, D., Castley, A., Fernandez, S. and French, M.A. (2014) Interferon-alpha, immune activation and immune dysfunction in treated HIV infection. Clinical & Translational Immunology, 3 (2). e10.

Rinaldi, C., Penhale, W.J., Stumbles, P.A., Tay, G. and Berry, C.M. (2014) Modulation of innate immune responses by influenza-specific ovine polyclonal antibodies used for prophylaxis. PLoS ONE, 9 (2).

Berry, C.M., Penhale, W.J. and Sangster, M.Y. (2014) Passive broad-spectrum influenza immunoprophylaxis. Influenza Research and Treatment, 2014 (Article ID 267594,).

Strickland, D.H., Fear, V., Shenton, S., Wikstrom, M.E., Zosky, G., Larcombe, A.N., Holt, P.G., Berry, C., von Garnier, C. and Stumbles, P.A. (2014) Persistent and compartmentalised disruption of dendritic cell subpopulations in the lung following influenza A virus infection. PLoS ONE, 9 (11). Article e111520.

Le, X., Poinern, G.E.J., Ali, N., Berry, C.M. and Fawcett, D. (2013) Engineering a biocompatible scaffold with either micrometre or nanometre scale surface topography for promoting protein adsorption and cellular response. International Journal of Biomaterials, 2013 . pp. 1-16.

James-Berry, C.M. (2013) Vaccine control of avian influenza H5N1 in poultry: Need for a positive marker. Journal of Vaccines & Vaccination, 04 (01). p. 168.

Poinern, G.E.J., Ali, N., Berry, C., Singh, P., Berchmans, S. and Fawcett, D. (2012) Biocompatibility of synthesised nano-porous anodic Aluminium oxide membranes for use as a cell culture substrate for Madin-Darby Canine Kidneys cells: A preliminary study. Journal of Tissue Science & Engineering, 3 (3).

Berry, C.M., Hertzog, P.J. and Mangan, N.E. (2012) Interferons as biomarkers and effectors: lessons learned from animal models. Biomarkers in Medicine, 6 (2). pp. 159-176.

Bayer, W., Lietz, R., Ontikatze, T., Johrden, L., Tenbusch, M., Nabi, G., Schimmer, S., Groitl, P., Wolf, H., Berry, C.M., Überla, K., Dittmer, U. and Wildner, O. (2011) Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes. Retrovirology, 8 (1). p. 75.

Chua, T-H, Leung, C.Y.H., Fang, H. E., Chow, Ch-K, Ma, S-K, Sia, S-F, Ng, I.H.Y., Fenwick, S.G., James, C.M., Chua, S.B., Chew, S.T., Kwang, J., Peiris, J.S.M. and Ellis, T.M. (2010) Evaluation of a subunit H5 vaccine and an inactivated H5N2 avian influenza marker vaccine in ducks challenged with Vietnamese H5N1 highly pathogenic avian influenza virus. Influenza Research and Treatment, 2010 . pp. 1-10.

James-Berry, C.M., Middleton, D., Mansfield, J.P., Fenwick, S.G. and Ellis, T.M. (2010) Use of a tetanus toxoid marker to allow differentiation of infected from vaccinated poultry without affecting the efficacy of a H5N1 avian influenza virus vaccine. Veterinary Record, 167 (18). pp. 695-699.

Gerlach, N., Gibbert, K., Alter, C., Nair, S., Zelinskyy, G., James, C.M. and Dittmer, U. (2009) Anti-retroviral effects of type I IFN subtypes in vivo. European Journal of Immunology, 39 (1). pp. 136-146.

Eade, J.A., Robertson, I.D.ORCID: 0000-0002-4255-4752 and James-Berry, C.M. (2009) Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats. Reproduction, 137 (6). pp. 913-922.

James-Berry, C.M., Foong, Y.Y., Mansfield, J.P., Vind, A.R., Fenwick, S.G. and Ellis, T.M. (2008) Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance. Vaccine, 26 (42). pp. 5345-5351.

James, C.M., Duffy, S., Pemberton, D., Armson, A. and Stumbles, P. (2008) Interferon subtype stimulation of dendritic cells: Key activators of anti-viral immunity. Cytokine, 43 (3). p. 309.

James-Berry, C.M., Abdad, M.Y., Mansfield, J.P., Jacobsen, H.K., Vind, A.R., Stumbles, P.A. and Bartlett, E.J. (2007) Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. Vaccine, 25 (10). pp. 1856-1867.

James-Berry, C.M., Foong, Y.Y., Mansfield, J.P., Fenwick, S.G. and Ellis, T.M. (2007) Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry. Vaccine, 25 (31). pp. 5892-5901.

Austin, B.A., James-Berry, C.M., Härle, P. and Carr, D.J.J. (2006) Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality. Biological Procedures Online, 8 (1). pp. 55-62.

Austin, B.A., James, C., Silverman, R.H. and Carr, D.J.J. (2005) Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-β during acute ocular herpes simplex virus type 1 infection. Journal of Immunology, 175 (2). pp. 1100-1106.

James, C.M., Bartlett, E.J., Mansfield, J.P. and Cull, V.S. (2005) Interferon subtype gene therapy for regulating cytomegalovirus disease. Methods in molecular medicine, 116 . pp. 207-219.

Bartlett, E.J., Lenzo, J.C., Sivamoorthy, S., Mansfield, J.P., Cull, V.S. and James, C.M. (2004) Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis. Immunology and Cell Biology, 82 (2). pp. 119-126.

Lenzo, J.C., Mansfield, J.P., Sivamoorthy, S., Cull, V.S. and James, C.M. (2003) Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-α therapy. Cellular Immunology, 223 (1). pp. 77-86.

Carr, D.J.J., Al-khatib, K., James, C.M. and Silverman, R. (2003) Interferon-β suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. Journal of Neuroimmunology, 141 (1-2). pp. 40-46.

Bartlett, E.J., Cull, V.S., Mowe, E.N., Mansfield, J.P. and James, C.M. (2003) Optimization of naked DNA delivery for interferon subtype immunotherapy in cytomegalovirus infection. Biological Procedures Online, 5 (1). pp. 43-52.

Cull, V.S., Tilbrook, P.A., Bartlett, E.J., Brekalo, N.L. and James, C.M. (2003) Type I interferon differential therapy for erythroleukemia: Specificity of STAT activation. Blood, 101 (7). pp. 2727-2735.

Lenzo, J.C., Fairweather, D., Cull, V., Shellam, G.R. and James, C.M. (2002) Characterisation of murine cytomegalovirus myocarditis: Cellular infiltration of the heart and virus persistence. Journal of Molecular and Cellular Cardiology, 34 (6). pp. 629-640.

Cull, V.S., Broomfield, S., Bartlett, E.J., Brekalo, N.L. and James, C.M. (2002) Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice. Gene Therapy, 9 (20). pp. 1369-1378.

Harle, P., Cull, V., Agbaga, M-P, Silverman, R., Williams, B.R.G., James, C. and Carr, D.J.J. (2002) Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. Journal of Virology, 76 (13). pp. 6558-6567.

Bartlett, E.J., Cull, V.S., Brekalo, N.L., Lenzo, J.C. and James, C.M. (2002) Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection. Immunology and Cell Biology, 80 (5). pp. 425-435.

Härle, P., Cull, V., Guo, L., Papin, J., Lawson, C. and Carr, D.J.J. (2002) Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antiviral Research, 56 (1). pp. 39-49.

Cull, V.S., Bartlett, E.J. and James, C.M. (2002) Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis. Immunology, 106 (3). pp. 428-437.

Lenzo, J.C. and Lawson, C.M. (2001) Cytomegalovirus-induced myocarditis - An animal model for understanding pathogenesis and therapy. International Antiviral News, 9 (11). pp. 166-169.

Fairweather, D., Kaya, Z., Shellam, G.R., Lawson, C.M. and Rose, N.R. (2001) From infection to autoimmunity. Journal of Autoimmunity, 16 (3). pp. 175-186.

Lenzo, J.C., Shellam, G.R. and Lawson, C.M. (2001) Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice. Antimicrobial agents and chemotherapy, 45 (5). pp. 1444-1449.

Lenzo, J.C., Fairweather, D., Shellam, G.R. and Lawson, C.M. (2001) Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor. Cellular Immunology, 213 (1). pp. 52-61.

Lawson, C.M. (2000) Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cellular and Molecular Life Sciences, 57 (4). pp. 552-560.

Bosio, E., Beilharz, M.W., Watson, M.W.ORCID: 0000-0002-6438-9225 and Lawson, C.M. (1999) Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo. Journal of Interferon & Cytokine Research, 19 (8). pp. 869-876.

Lawson, C.M. and Beilharz, M.W. (1999) Low-dose oral use of interferon inhibits virally induced myocarditis. Journal of Interferon & Cytokine Research, 19 (8). pp. 863-867.

Yeow, W.S., Lawson, C.M. and Beilharz, M.W. (1998) Antiviral activities of individual murine IFN-alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication. Journal of Immunology, 160 (6). pp. 2932-2939.

Fairweather, D., Lawson, C.M., Chapman, A.J., Brown, C.M.S., Booth, T.W.M., Papadimitriou, J.M. and Shellam, G.R. (1998) Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin. Immunology, 94 (2). pp. 263-270.

Lawson, C.M., Yeow, W-S, Lee, C.M. and Beilharz, M.W. (1997) In vivo expression of an interferon-α gene by intramuscular injection of naked DNA. Journal of Interferon & Cytokine Research, 17 (5). pp. 255-261.

Beilharz, M.W., McDonald, W., Watson, M.W.ORCID: 0000-0002-6438-9225, Heng, J., McGeachie, J. and Lawson, C.M. (1997) Low-dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo. Journal of Interferon & Cytokine Research, 17 (10). pp. 625-630.

Epstein, S.L., Lo, C.Y., Misplon, J.A., Lawson, C.M., Hendrickson, B.A., Max, E.E. and Subbarao, K. (1997) Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. The Journal of Immunology, 158 (3). pp. 1222-1230.

Blechynden, L.M., Lawson, M.A., Tabarias, H., Garlepp, M.J., Sherman, J., Raben, N. and Lawson, C.M. (1997) Myositis induced by naked DNA immunization with the gene for Histidyl-tRNA synthetase. Human Gene Therapy, 8 (12). pp. 1469-1480.

Blechynden, L.M., Lawson, C.M. and Garlepp, M.J. (1996) Sequence and polymorphism analysis of the murine gene encoding histidyl-tRNA synthetase. Gene, 178 (1-2). pp. 151-156.

Subbarao, E.K., Park, E.J., Lawson, C.M., Chen, A.Y. and Murphy, B.R. (1995) Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine. Journal of Virology, 69 (10). pp. 5969-5799.

Lawson, C.M., Bennink, J.R., Restifo, N.P., Yewdell, J.W. and Murphy, B.R. (1994) Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. Journal of Virology, 68 (6). pp. 3505-3511.

Epstein, S.L., Misplon, J.A., Lawson, C.M., Subbarao, E.K., Connors, M. and Murphy, B.R. (1993) Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. Journal of Immunology, 150 (12). pp. 5484-5493.

Lawson, C.M., Subbarao, E.K. and Murphy, B.R. (1993) Erratum: Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus (Virology (506- 510)). Virology, 195 (1). p. 302.

Lawson, C.M., O'Donoghue, H.L., Bartholomaeus, W.H. and Reed, W.D. (1992) Genetic control of mouse cytomegalovirus-induced myocarditis. Immunology, 69 (1). pp. 20-26.

Lawson, C.M., O'Donoghue, H.L. and Reed, W.D. (1992) Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunology, 75 (3). pp. 513-519.

Lawson, C.M., Subbarao, E.K. and Murphy, B.R. (1992) Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus. Virology, 191 (1). pp. 506-510.

Lawson, C.M., O'Donoghue, H.L., Farrell, H.E., Shellam, G.R. and Reed, W.D. (1991) Murine anti-cytomegalovirus monoclonal antibodies with autoreactivity. Immunology, 72 (3). pp. 426-433.

O'Donoghue, H.L., Lawson, C.M. and Reed, W.D. (1990) Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis. Immunology, 71 (1). pp. 20-28.

Lawson, C.M., O'Donoghue, H.L. and Reed, W.D. (1989) The role of T cells in mouse cytomegalovirus myocarditis. Immunology, 67 (1). pp. 132-134.

Lawson, C.M., Hodgkin, P.D. and Shellam, G.R. (1989) The effect of cyclosporin on major histocompatibility complex-linked resistance to murine cytomegalovirus. Journal of General Virology, 70 (5). pp. 1253-1259.

Bartholomaeus, W.N., O'Donoghue, H., Foti, D., Lawson, C.M., Shellam, G.R. and Reed, W.D. (1988) Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology, 64 (3). pp. 397-405.

Lawson, C.M., Grundy, J.E. and Shellam, G.R. (1988) Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. Journal of General Virology, 69 (8). pp. 1987-1998.

Lawson, C.M., Grundy, J.E. and Shellam, G.R. (1987) Delayed-type hypersensitivity responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. Journal of General Virology, 68 (9). pp. 2379-2388.

Non-refereed Article

James, C.M. (1983) Australia's microbiological role in the third world. Australian Microbiologist . pp. 4-8.

Conference Paper

James, C.M., Lisciandro, J., Gerlach, N., Dittmer, U. and Stumbles, P.A. (2007) Interferon-alpha subtypes differentially enhance dendritic cell biology. In: International Society for Interferon and Cytokine Research, Interferon Anniversary Meeting, 16 - 19 September, Oxford, England

Conference Item

Strautins, K., Tschochner, M., Berry, C., James, I., Leary, S., Choo, L., Clark, H., Pedrini, M., Kermode, A., Carroll, W. and Nolan, D. (2016) Identifying novel potential cross-reactive targets in Multiple Sclerosis. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Strautins, K., Tschochner, M., James, I., Leary, S., Choo, L., Walters, S., Pedrini, M., Dunn, D., Berry, C., Clark, H., Cooper, D., Kermode, A., Carroll, W. and Nolan, D. (2015) Investigating the role of EBV infection in multiple sclerosis pathogenesis. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Strautins, K., Tschochner, M., James, I., Berry, C. and Nolan, D. (2013) Influence of gender, genetic factors and Epstein-Barr Virus antibody profiles, on Multiple Sclerosis risk. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Olney, A., Almeida, C.M., Berry, C., John, M., Witt, C. and D'Orsogna, L. (2013) Stimulating HIV memory CD8+ T cells with allogeneic cell immunotherapy. In: ASMR WA Scientific Symposium, 5th June 2013, Perth, WA.

Strautins, K., Tschochner, M., Berry, C. and Nolan, D. (2012) Development of an anti-Epstein-Barr Virus nuclear antigen-1 ELISA and investigation of B-cell-epitope specific antibodies in Multiple Sclerosis patients. In: Murdoch University Postgraduate Student Association (MUPSA) Multidisciplinary Conference, 27 September 2012, Murdoch University, Murdoch.

Strautins, K., Tschochner, M., James, I., Berry, C.M. and Nolan, D. (2012) Epstein-Barr virus (EBV) - specific antibodies in multiple sclerosis patients, including targeted investigation of a candidate EBV nuclear antigen-1 (EBNA-1) B cell epitope. In: 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 10 - 13 October, Lyon, France.

Strautins, K., Tschochner, M., Nolan, D. and Berry, C. (2012) Investigating Epstein-Barr virus (EBV) antibodies in Multiple Sclerosis patients, and development of an anti-EBV nuclear antigen-1 B cell epitope ELISA. In: ASMR Medical Research Week, 7 June 2012, Perth, Western Australia.

Carr, D.J., Cull, V. and James, C.M. (2002) Mouse cornea transfected with plasmid containing interferon-b transgene is superior to other Type I interferon transgenes in antagonizing viral-medicated mortality. In: Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), 5 - 10 May, Fort Lauderdale, Florida, USA.

Book Chapter

Garlepp, M.J., Blechynden, L., Tabarias, H., Lawson, C.M., Van Bockxmeer, F. and Mastaglia, F.L. (1998) Genetic factors in sporadic inclusion-body myositis. In: Askanas, V., Serratrice, G. and Engel, W.K., (eds.) Inclusion-Body Myositis and Myopathies. Cambridge University Press, Cambridge, pp. 177-188.

Epstein, S.L., Lo, C-Y, Misplon, J.A., Murphy, B.R., Lawson, C.M. and Subbarao, E.K. (1995) Mediators of heterosubtypic immunity to influenza A virus infection in mice. In: Chanock, R.M., Brown, F., Ginsberg, H.S. and Norrby, E., (eds.) Vaccines 95, Molecular Approaches to the Control of Infectious Diseases. Cold Spring Harbor Laboratories, Cold Spring Harboor, pp. 393-398.


Ellis, T.M., Fenwick, S.G. and Berry, C.M. (2007) Differentiating therapeutic composition. Patent, WO 2007053899 A1 .

This list was generated on Fri Feb 3 23:29:57 2023 UTC.